![Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table](https://covid19-sciencetable.ca/wp-content/uploads/2020/12/Figure-1.jpg)
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
![Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7013e3_COVIDVaccineFieldEffectiveness_IMAGE_29Mar21_v2_1200x675.jpg)
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
![Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1088/F4.medium.jpg)
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x627.jpg?_=39294)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota](https://www.childrensmn.org/assets/img/covid19-vac-schedule-chart-01.png)
CDC updates COVID-19 vaccine recommended wait time to eight weeks for some groups | Children's Minnesota
![Comparing the longer-term effectiveness of a single dose of the Pfizer- BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine Comparing the longer-term effectiveness of a single dose of the Pfizer- BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine](https://www.thelancet.com/cms/attachment/1bba1167-47f6-431c-bdce-0faee0f92314/gr1_lrg.jpg)
Comparing the longer-term effectiveness of a single dose of the Pfizer- BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum - eClinicalMedicine
![Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet](https://www.thelancet.com/cms/asset/4a4effe5-53f5-4f96-9256-36262c6efc01/gr1.jpg)
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
![Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1088/F2.large.jpg)
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7011e2-F.gif?_=83873)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![What is the evidence for extending the SARS-CoV-2 (COVID-19) vaccine dosing schedule? | British Columbia Medical Journal What is the evidence for extending the SARS-CoV-2 (COVID-19) vaccine dosing schedule? | British Columbia Medical Journal](https://bcmj.org/sites/default/files/BCMJ_Vol63_No2-vaccine-dosing_web_Table.jpg)